Bandeira ID

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA.

6 papers · ORCID

ArticleKetamine

Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Tucciarone JM, Bandeira ID, Blasey C +13

Europe PMC2026
ArticleIbogaine

Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol.

Geoly AD, Coetzee JP, Buchanan DM +16

Europe PMC2026
ArticleKetamine

Methodological considerations for interpreting ketamine-naltrexone trials in depression.

Bandeira ID, Jelen LA, Tucciarone JM +3

Europe PMC2025
ArticleKetamine

Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.

Alves-Pereira R, Fontes M, Cordeiro V +7

Europe PMC2024
ArticleKetamine

Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.

Echegaray MVF, Mello RP, Magnavita GM +16

Europe PMC2025
ArticleKetamine

Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.

Caliman-Fontes AT, Leal GC, Correia-Melo FS +17

Europe PMC2023